Evidence map›Paper›PMID 28783043›Full record

ArticleThe Journal of clinical investigation2017

NBEAL2 is required for neutrophil and NK cell function and pathogen defense.

John M Sowerby, David C Thomas, Simon Clare, Marion Espéli, Jose A Guerrero, Kim Hoenderdos, Katherine Harcourt, Morgan Marsden, Juneid Abdul-Karim, Mathew Clement and 12 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Genomic and transcriptomic investigations of the evolutionary transition from oviparity to viviparity.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 2 countries.

John M SowerbyDepartment of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
David C ThomasDepartment of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Simon ClareWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom.
Marion EspéliDepartment of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Jose A GuerreroDepartment of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Kim HoenderdosDepartment of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Katherine HarcourtWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom.
Morgan MarsdenDivision of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Juneid Abdul-KarimDivision of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Mathew ClementDivision of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Robin AntrobusCambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Yagnesh UmraniaCambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Philippa R BartonCambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Shaun M FlintDepartment of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Jatinder K JussDepartment of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Alison M CondliffeDepartment of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Paul A LyonsDepartment of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Ian R HumphreysDivision of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Edwin R ChilversDepartment of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Willem H OuwehandWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom.
Gordon DouganDepartment of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Kenneth Gc SmithDepartment of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
University of Cambridge · GBCardiff University · GBNHS Blood and Transplant · GBWellcome Sanger Institute · GBUniversité Paris-Sud · FR

Funding

Medical Research Council MR/L019027/1Wellcome Trust 200871/Z/16/Z
6 · The paper itself

Abstract

Mutations in the human NBEAL2 gene cause gray platelet syndrome (GPS), a bleeding diathesis characterized by a lack of α granules in platelets. The functions of the NBEAL2 protein have not been explored outside platelet biology, but there are reports of increased frequency of infection and abnormal neutrophil morphology in patients with GPS. We therefore investigated the role of NBEAL2 in immunity by analyzing the phenotype of Nbeal2-deficient mice. We found profound abnormalities in the Nbeal2-deficient immune system, particularly in the function of neutrophils and NK cells. Phenotyping of Nbeal2-deficient neutrophils showed a severe reduction in granule contents across all granule subsets. Despite this, Nbeal2-deficient neutrophils had an enhanced phagocyte respiratory burst relative to Nbeal2-expressing neutrophils. This respiratory burst was associated with increased expression of cytosolic components of the NADPH oxidase complex. Nbeal2-deficient NK cells were also dysfunctional and showed reduced degranulation. These abnormalities were associated with increased susceptibility to both bacterial (Staphylococcus aureus) and viral (murine CMV) infection in vivo. These results define an essential role for NBEAL2 in mammalian immunity.

Indexed as

MutationAnimalsBlood PlateletsBlood ProteinsCytosolGray Platelet SyndromeHumansImmune SystemImmunophenotypingKiller Cells, NaturalMiceMice, KnockoutNADPH OxidasesNeutrophilsPhenotypeStaphylococcal InfectionsBlood ProteinsNADPH OxidasesNBEAL2 protein, human

Identifiers

PMID28783043
PMCPMC5669559
OpenAlexW2743635553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.